FDA approves AZOR

[caption id="attachment_51" align="alignright" width="255" caption="Azor"]Azor[/caption]

The United States food and drug adminstration (FDA) approved Azor as first line treatment for high sever blood pressure. AZOR is formulated by Daiichi Sankyo, Inc. It’s a combination of Amlodipine as Amlodipine besylate and Olmesartan medoxomil. It’s prescribed for patients suffering from high blood pressure that can’t be controlled by the normal single antihypertensive theraby.

Click to continue reading “FDA approves AZOR”


WordPress Loves AJAX